Beulah Ji

Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis

Richard Furie, Brad H. Rovin, Frédéric Houssiau et al. · New England Journal of Medicine · 2020 · 973 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response

Ronald van Vollenhoven, Michelle Petri, Ricard Cervera et al. · Annals of the Rheumatic Diseases · 2012 · 407 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis

Brad H. Rovin, Richard Furie, Y K Onno Teng et al. · Kidney International · 2021 · 198 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial

Hermine I. Brunner, Carlos Abud‐Mendoza, Diego Oscar Viola et al. · Annals of the Rheumatic Diseases · 2020 · 193 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A Randomized Controlled Study

David Jayne, Daniël Blockmans, Raashid Luqmani et al. · Arthritis & Rheumatology · 2019 · 139 citations · Full text

Life Sciences, Clinical Sciences, Pharmacology +16